Chapter/Section Purchase

1 Study Coverage
1.1 Oxaliplatin Injection Product Introduction
1.2 Market by Type
1.2.1 Global Oxaliplatin Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Other
1.3 Market by Application
1.3.1 Global Oxaliplatin Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oxaliplatin Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Oxaliplatin Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Oxaliplatin Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oxaliplatin Injection Sales by Region
2.4.1 Global Oxaliplatin Injection Sales by Region (2017-2022)
2.4.2 Global Sales Oxaliplatin Injection by Region (2023-2028)
2.5 Global Oxaliplatin Injection Revenue by Region
2.5.1 Global Oxaliplatin Injection Revenue by Region (2017-2022)
2.5.2 Global Oxaliplatin Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oxaliplatin Injection Sales by Manufacturers
3.1.1 Global Top Oxaliplatin Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Oxaliplatin Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oxaliplatin Injection in 2021
3.2 Global Oxaliplatin Injection Revenue by Manufacturers
3.2.1 Global Oxaliplatin Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Oxaliplatin Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oxaliplatin Injection Revenue in 2021
3.3 Global Oxaliplatin Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oxaliplatin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oxaliplatin Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oxaliplatin Injection Sales by Type
4.1.1 Global Oxaliplatin Injection Historical Sales by Type (2017-2022)
4.1.2 Global Oxaliplatin Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Oxaliplatin Injection Sales Market Share by Type (2017-2028)
4.2 Global Oxaliplatin Injection Revenue by Type
4.2.1 Global Oxaliplatin Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Oxaliplatin Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oxaliplatin Injection Revenue Market Share by Type (2017-2028)
4.3 Global Oxaliplatin Injection Price by Type
4.3.1 Global Oxaliplatin Injection Price by Type (2017-2022)
4.3.2 Global Oxaliplatin Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oxaliplatin Injection Sales by Application
5.1.1 Global Oxaliplatin Injection Historical Sales by Application (2017-2022)
5.1.2 Global Oxaliplatin Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Oxaliplatin Injection Sales Market Share by Application (2017-2028)
5.2 Global Oxaliplatin Injection Revenue by Application
5.2.1 Global Oxaliplatin Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Oxaliplatin Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oxaliplatin Injection Revenue Market Share by Application (2017-2028)
5.3 Global Oxaliplatin Injection Price by Application
5.3.1 Global Oxaliplatin Injection Price by Application (2017-2022)
5.3.2 Global Oxaliplatin Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oxaliplatin Injection Market Size by Type
6.1.1 North America Oxaliplatin Injection Sales by Type (2017-2028)
6.1.2 North America Oxaliplatin Injection Revenue by Type (2017-2028)
6.2 North America Oxaliplatin Injection Market Size by Application
6.2.1 North America Oxaliplatin Injection Sales by Application (2017-2028)
6.2.2 North America Oxaliplatin Injection Revenue by Application (2017-2028)
6.3 North America Oxaliplatin Injection Market Size by Country
6.3.1 North America Oxaliplatin Injection Sales by Country (2017-2028)
6.3.2 North America Oxaliplatin Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Oxaliplatin Injection Market Size by Type
7.1.1 Europe Oxaliplatin Injection Sales by Type (2017-2028)
7.1.2 Europe Oxaliplatin Injection Revenue by Type (2017-2028)
7.2 Europe Oxaliplatin Injection Market Size by Application
7.2.1 Europe Oxaliplatin Injection Sales by Application (2017-2028)
7.2.2 Europe Oxaliplatin Injection Revenue by Application (2017-2028)
7.3 Europe Oxaliplatin Injection Market Size by Country
7.3.1 Europe Oxaliplatin Injection Sales by Country (2017-2028)
7.3.2 Europe Oxaliplatin Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oxaliplatin Injection Market Size by Type
8.1.1 Asia Pacific Oxaliplatin Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Oxaliplatin Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Oxaliplatin Injection Market Size by Application
8.2.1 Asia Pacific Oxaliplatin Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Oxaliplatin Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Oxaliplatin Injection Market Size by Region
8.3.1 Asia Pacific Oxaliplatin Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Oxaliplatin Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Oxaliplatin Injection Market Size by Type
9.1.1 Latin America Oxaliplatin Injection Sales by Type (2017-2028)
9.1.2 Latin America Oxaliplatin Injection Revenue by Type (2017-2028)
9.2 Latin America Oxaliplatin Injection Market Size by Application
9.2.1 Latin America Oxaliplatin Injection Sales by Application (2017-2028)
9.2.2 Latin America Oxaliplatin Injection Revenue by Application (2017-2028)
9.3 Latin America Oxaliplatin Injection Market Size by Country
9.3.1 Latin America Oxaliplatin Injection Sales by Country (2017-2028)
9.3.2 Latin America Oxaliplatin Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oxaliplatin Injection Market Size by Type
10.1.1 Middle East and Africa Oxaliplatin Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oxaliplatin Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Oxaliplatin Injection Market Size by Application
10.2.1 Middle East and Africa Oxaliplatin Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oxaliplatin Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Oxaliplatin Injection Market Size by Country
10.3.1 Middle East and Africa Oxaliplatin Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oxaliplatin Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Corporation Information
11.1.2 Sanofi-Aventis Overview
11.1.3 Sanofi-Aventis Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi-Aventis Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi-Aventis Recent Developments
11.2 Yakult honsha
11.2.1 Yakult honsha Corporation Information
11.2.2 Yakult honsha Overview
11.2.3 Yakult honsha Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Yakult honsha Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Yakult honsha Recent Developments
11.3 Dr Reddy's laboratories
11.3.1 Dr Reddy's laboratories Corporation Information
11.3.2 Dr Reddy's laboratories Overview
11.3.3 Dr Reddy's laboratories Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Dr Reddy's laboratories Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dr Reddy's laboratories Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Overview
11.4.3 Sun Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sun Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceutical Recent Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Overview
11.5.3 Teva Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Teva Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Corporation Information
11.6.2 Fresenius Kabi Overview
11.6.3 Fresenius Kabi Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Fresenius Kabi Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Fresenius Kabi Recent Developments
11.7 Hospira(Pfizer)
11.7.1 Hospira(Pfizer) Corporation Information
11.7.2 Hospira(Pfizer) Overview
11.7.3 Hospira(Pfizer) Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hospira(Pfizer) Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hospira(Pfizer) Recent Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Overview
11.8.3 Mylan Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mylan Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Corporation Information
11.9.2 Jiangsu Hengrui Medicine Overview
11.9.3 Jiangsu Hengrui Medicine Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Jiangsu Hengrui Medicine Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jiangsu Hengrui Medicine Recent Developments
11.10 Nanjing Pharmaceutical Factory
11.10.1 Nanjing Pharmaceutical Factory Corporation Information
11.10.2 Nanjing Pharmaceutical Factory Overview
11.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nanjing Pharmaceutical Factory Recent Developments
11.11 Jiangsu Aosaikang Pharmaceutical
11.11.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
11.11.2 Jiangsu Aosaikang Pharmaceutical Overview
11.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Corporation Information
11.12.2 Qilu Pharmaceutical Overview
11.12.3 Qilu Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Qilu Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Qilu Pharmaceutical Recent Developments
11.13 Hisun Pharmaceutical
11.13.1 Hisun Pharmaceutical Corporation Information
11.13.2 Hisun Pharmaceutical Overview
11.13.3 Hisun Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hisun Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hisun Pharmaceutical Recent Developments
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Corporation Information
11.14.2 Lunan Pharmaceutical Overview
11.14.3 Lunan Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Lunan Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Lunan Pharmaceutical Recent Developments
11.15 Luoxin
11.15.1 Luoxin Corporation Information
11.15.2 Luoxin Overview
11.15.3 Luoxin Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Luoxin Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Luoxin Recent Developments
11.16 Halfsky Pharmacy
11.16.1 Halfsky Pharmacy Corporation Information
11.16.2 Halfsky Pharmacy Overview
11.16.3 Halfsky Pharmacy Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Halfsky Pharmacy Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Halfsky Pharmacy Recent Developments
11.17 YRPG
11.17.1 YRPG Corporation Information
11.17.2 YRPG Overview
11.17.3 YRPG Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 YRPG Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 YRPG Recent Developments
11.18 Hainan Jinrui Pharmaceutical
11.18.1 Hainan Jinrui Pharmaceutical Corporation Information
11.18.2 Hainan Jinrui Pharmaceutical Overview
11.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Hainan Jinrui Pharmaceutical Recent Developments
11.19 Jari Pharmaceutical
11.19.1 Jari Pharmaceutical Corporation Information
11.19.2 Jari Pharmaceutical Overview
11.19.3 Jari Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Jari Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Jari Pharmaceutical Recent Developments
11.20 Chiatai Tianqing
11.20.1 Chiatai Tianqing Corporation Information
11.20.2 Chiatai Tianqing Overview
11.20.3 Chiatai Tianqing Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Chiatai Tianqing Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Chiatai Tianqing Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oxaliplatin Injection Industry Chain Analysis
12.2 Oxaliplatin Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oxaliplatin Injection Production Mode & Process
12.4 Oxaliplatin Injection Sales and Marketing
12.4.1 Oxaliplatin Injection Sales Channels
12.4.2 Oxaliplatin Injection Distributors
12.5 Oxaliplatin Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oxaliplatin Injection Industry Trends
13.2 Oxaliplatin Injection Market Drivers
13.3 Oxaliplatin Injection Market Challenges
13.4 Oxaliplatin Injection Market Restraints
14 Key Findings in The Global Oxaliplatin Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer